Key result
Joint remnant cholesterol and TyG index assessment predicts CV outcomes in statin-treated patients.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
A lthough pharmacologic treatment of low- density lipoprotein cholesterol (LDL-C) with lipid-lowering therapy has a pivotal effect on the control of atherosclerotic cardiovascular diseases (ASCVDs), the residual cardiovascular risks remain in patients with established ASCVDs. 1 Recently, the triglyceride glucose (TyG) index,
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question. The joint assessment of remnant cholesterol and the triglyceride glucose index predicts cardiovascular outcomes in statin-treated patients.
Synapse has enriched 10 related papers. Consider them for comparative context: